INTERCYTEX GROUP
Intercytex Group plc, a development stage biotechnology company, engages in the research, development, and commercialization of cell-based therapies for the repair and regeneration of skin and hair. The company, using its integrated cell technology platform, develops living, human cell-based products. Its product programs in development include VAVELTA, a facial rejuvenation and skin damage repair product, which completed Phase II trials; SHEF-1-Stem Cell Line, which would develop a cure for AMD... , the leading cause of blindness in the elderly; ICX-TRC, a hair regeneration product that completed Phase II trials; and ICX-SKN, a skin graft replacement for burns and acute wounds, which completed Phase I trial. The company was founded in 2000 and is headquartered in Cambridge, the United Kingdom.
INTERCYTEX GROUP
Social Links:
Industry:
Beauty Biotechnology Medical
Founded:
1999-01-01
Address:
Cambridge, Cambridgeshire, United Kingdom
Country:
United Kingdom
Website Url:
http://www.intercytex.com
Total Employee:
1+
Status:
Active
Email Addresses:
[email protected]
Total Funding:
43.16 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Office 365 Mail Microsoft Azure DNS GoDaddy DNS Pound Sterling GoDaddy SSL Google Adsense Heart Internet
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2008-12-22 | Axordia | Axordia acquired by Intercytex Group | N/A |
Investors List
Excalibur Fund Managers
Excalibur Fund Managers investment in Series D - Intercytex Group
3i Group
3i Group investment in Series D - Intercytex Group
NIF Ventures
NIF Ventures investment in Series D - Intercytex Group
Avlar BioVentures
Avlar BioVentures investment in Series D - Intercytex Group
Scottish Equity Partners
Scottish Equity Partners investment in Series D - Intercytex Group
Scottish Equity Partners
Scottish Equity Partners investment in Venture Round - Intercytex Group
Scottish Equity Partners
Scottish Equity Partners investment in Venture Round - Intercytex Group
Avlar BioVentures
Avlar BioVentures investment in Venture Round - Intercytex Group
Official Site Inspections
http://www.intercytex.com
- Host name: 104.21.5.180
- IP address: 104.21.5.180
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
